Shanghai Pharmaceuticals Holding Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai Pharmaceuticals Holding has a total shareholder equity of CN¥82.1B and total debt of CN¥53.8B, which brings its debt-to-equity ratio to 65.5%. Its total assets and total liabilities are CN¥217.4B and CN¥135.3B respectively. Shanghai Pharmaceuticals Holding's EBIT is CN¥8.2B making its interest coverage ratio 6. It has cash and short-term investments of CN¥37.2B.
Key information
65.5%
Debt to equity ratio
CN¥53.78b
Debt
Interest coverage ratio | 6x |
Cash | CN¥37.18b |
Equity | CN¥82.09b |
Total liabilities | CN¥135.33b |
Total assets | CN¥217.42b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2607's short term assets (CN¥167.4B) exceed its short term liabilities (CN¥125.3B).
Long Term Liabilities: 2607's short term assets (CN¥167.4B) exceed its long term liabilities (CN¥10.1B).
Debt to Equity History and Analysis
Debt Level: 2607's net debt to equity ratio (20.2%) is considered satisfactory.
Reducing Debt: 2607's debt to equity ratio has reduced from 65.7% to 65.5% over the past 5 years.
Debt Coverage: 2607's debt is not well covered by operating cash flow (4.4%).
Interest Coverage: 2607's interest payments on its debt are well covered by EBIT (6x coverage).